Niopeg 6 mg

Niopeg 6 mg is a subcutaneous solution containing pegfilgrastim, used to support white blood cell recovery during chemotherapy. This medication helps reduce infection risk in cancer patients.

Niopeg 6 mg is primarily used to stimulate the production of white blood cells in individuals undergoing chemotherapy. By supporting the immune system, it helps reduce the risk of infections that can occur as a side effect of cancer treatment. This medication is often prescribed to patients receiving myelosuppressive chemotherapy to aid in the recovery of bone marrow function.

Common effects of Niopeg 6 mg may include bone pain, which is typically mild to moderate and temporary. Some individuals may also experience fatigue, headache, or mild allergic reactions at the injection site. These effects are generally manageable and should be discussed with a healthcare provider if they persist or worsen.

Niopeg 6 mg should be handled with care, ensuring proper storage and administration as directed. It is important to inform healthcare providers of any allergies or medical conditions before use. This medication should not be used by individuals with a history of severe allergic reactions to pegfilgrastim or similar products.

Niopeg 6 mg may interact with other medications, particularly those that affect the immune system or bone marrow. It is advisable to consult a healthcare provider about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol and certain foods may also influence the effectiveness of this medication.